Showing 1 - 20 results of 35 for search 'Ron H J Mathijssen', query time: 0.04s
Refine Results
-
1
-
2
-
3
Clinical <i>CYP2D6</i> Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy by Tessa A. M. Mulder, Mirjam de With, Marzia del Re, Romano Danesi, Ron H. J. Mathijssen, Ron H. N. van Schaik
Published 2021-02-01
Article -
4
-
5
Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients by Daan A.C. Lanser, Maud B.A. Van der Kleij, G.D. Marijn Veerman, Neeltje Steeghs, Alwin D.R. Huitema, Ron H.J. Mathijssen, Esther Oomen-de Hoop
Published 2023-07-01
Article -
6
Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients by Femke M. de Man, Ruben A.G. van Eerden, Esther Oomen-de Hoop, Joris N. Veraart, Nadia van Doorn, Leni van Doorn, Ate van der Gaast, Ron H.J. Mathijssen
Published 2019-06-01
Article -
7
-
8
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients by Leni van Doorn, Marie-Rose B. S. Crombag, Hánah N. Rier, Jeroen L. A. van Vugt, Charlotte van Kesteren, Sander Bins, Ron H. J. Mathijssen, Mark-David Levin, Stijn L. W. Koolen
Published 2021-01-01
Article -
9
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma by Koen G. A. M. Hussaarts, Leni van Doorn, Sander Bins, Dave Sprengers, Peter de Bruijn, Roelof W. F. van Leeuwen, Stijn L. W. Koolen, Teun van Gelder, Ron H. J. Mathijssen
Published 2021-01-01
Article -
10
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities by Yang Li, Yan Jin, Hanieh Taheri, Keith T. Schmidt, Alice A. Gibson, Stefan A. J. Buck, Eric D. Eisenmann, Ron H. J. Mathijssen, William D. Figg, Sharyn D. Baker, Alex Sparreboom, Shuiying Hu
Published 2022-09-01
Article -
11
Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale by Bram C. Agema, Sanne M. Buijs, Sebastiaan D.T. Sassen, Thomas E. Mürdter, Mathias Schwab, Birgit C.P. Koch, Agnes Jager, Ron H.N. van Schaik, Ron H.J. Mathijssen, Stijn L.W. Koolen
Published 2023-04-01
Article -
12
Influence of Genetic Variation in <i>COMT</i> on Cisplatin-Induced Nephrotoxicity in Cancer Patients by Bram C. Agema, Stijn L.W. Koolen, Mirjam de With, Nadia van Doorn, Niels Heersche, Esther Oomen-de Hoop, Sabine Visser, Joachim G.J.V. Aerts, Sander Bins, Ron H.N. van Schaik, Ron H.J. Mathijssen
Published 2020-03-01
Article -
13
Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib by Anyue Yin, G. D. Marijn Veerman, Johan G. C. vanHasselt, Christi M. J. Steendam, Hendrikus Jan Dubbink, Henk‐Jan Guchelaar, Lena E. Friberg, Anne‐Marie C. Dingemans, Ron H. J. Mathijssen, Dirk Jan A. R. Moes
Published 2024-04-01
Article -
14
Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634 by Florence Atrafi, Ruben A. G. van Eerden, Stijn L. W. Koolen, Peter de Bruijn, Cristianne J. F. Rijcken, Rob Hanssen, Ferry A. L. M. Eskens, Martijn P. Lolkema, Esther Oomen-de Hoop, Jeffrey Damman, Ron H. J. Mathijssen
Published 2021-07-01
Article -
15
Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer by Eelke L.A. Toxopeus, Femke M. de Man, Nanda Krak, Katharina Biermann, Annemieke J.M. Nieuweboer, Lena E. Friberg, Esther Oomen-de Hoop, Jan J.B. van Lanschot, Joel Shapiro, Bas P.L. Wijnhoven, Ron H.J. Mathijssen
Published 2019-02-01
Article -
16
Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy by Evelien J. M. Kuip, Wendy H. Oldenmenger, Esther Oomen-de Hoop, Gerda M. Verduijn, Martine F. Thijs-Visser, Peter de Bruijn, Esther van Meerten, Stijn L. W. Koolen, Ron H. J. Mathijssen, Carin C. D. van der Rijt
Published 2018-11-01
Article -
17
Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer by G.D. Marijn Veerman, Daan P. Hurkmans, Marthe S. Paats, Esther Oomen-de Hoop, Cor H. van der Leest, Eric R.E. van Thiel, Joachim G.J.V. Aerts, Roelof W. van Leeuwen, Anne-Marie C. Dingemans, Ron H.J. Mathijssen
Published 2022-11-01
Article -
18
Germline Variation in <i>PDCD1</i> Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy by Mirjam de With, Daan P. Hurkmans, Esther Oomen-de Hoop, Ayoub Lalouti, Sander Bins, Samira El Bouazzaoui, Mandy van Brakel, Reno Debets, Joachim G. J. V. Aerts, Ron H. N. van Schaik, Ron H. J. Mathijssen, Astrid A. M. van der Veldt
Published 2021-03-01
Article -
19
Gastrointestinal Stromal Tumours (GIST) in Young Adult (18–40 Years) Patients: A Report from the Dutch GIST Registry by Nikki S. IJzerman, Cas Drabbe, Dide den Hollander, Mahmoud Mohammadi, Hester van Boven, Ingrid M.E. Desar, Hans Gelderblom, Dirk J. Grünhagen, An K.L. Reyners, Max M. van Noesel, Ron H.J. Mathijssen, Neeltje Steeghs, Winette T.A. van der Graaf
Published 2020-03-01
Article -
20
mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer by Khrystany T. Isebia, Bianca Mostert, Teoman Deger, Jaco Kraan, Vanja deWeerd, Esther Oomen‐de Hoop, Paul Hamberg, Brigitte C. M. Haberkorn, Helgi H. Helgason, Ronald deWit, Ron H. J. Mathijssen, Martijn P. Lolkema, Saskia M. Wilting, Job vanRiet, John W. M. Martens
Published 2023-09-01
Article